Jci_page_head_homepage_01 Jci_page_head_homepage_02
Christophe M. Filippi, Elizabeth A. Estes, Janine E. Oldham, Matthias G. von Herrath
Published in Volume 119, Issue 6
J Clin Invest. 2009; 119(6):1515–1523 doi:10.1172/JCI38503
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 2
CVB3 or LCMV infection of prediabetic NOD mice causes PD-L1 upregulation on lymphoid cells and prevents the expansion of IGRP-specific CD8+ T cells expressing PD-1.

(A) Percentage of PD-L1hi cells over time in the pancreatic LN and spleen of individual NOD mice left untreated or infected at 9 weeks of age with CVB3 (orange triangles) or LCMV (green inverted triangles), as measured by flow cytometry. (B) PD-1 and CD44 expression by IGRP-specific or -nonspecific (Other) CD8+ T cells in the pancreatic LN and spleen of 9-week-old naive NOD mice, as measured by flow cytometry after staining with NRP-V7 tetramer. Shown are representative flow cytometry contour plots. Numbers indicate the percentage of PD-1+CD44hi cells ± SD for 3 individual mice per group. (C) Percentage of IGRP-specific CD8+ T cells over time in the pancreatic LN and spleen of individual NOD mice left untreated or infected at 9 weeks of age with CVB3 or LCMV, as measured by flow cytometry after staining with NRP-V7 tetramer. In A and C, symbols represent individual values, and horizontal lines denote mean. *P < 0.05, **P < 0.005, ***P < 0.001.